Applications of carbonic anhydrase inhibitors and activators in therapy
about
The plasma membrane carbonic anhydrase in murine hepatocytes identified as isozyme XIV.Carbonic anhydrase isozymes IX and XII in gastric tumorsThree-component synthesis and carbonic anhydrase inhibitory properties of novel octahydroacridines incorporating sulfaguanidine scaffold.Indisulam: an anticancer sulfonamide in clinical development.A perspective on quantitative structure-activity relationships and carbonic anhydrase inhibitors.Lansoprazole and carbonic anhydrase IX inhibitors sinergize against human melanoma cells.Plasmodium falciparum carbonic anhydrase is a possible target for malaria chemotherapy.The sulfamide motif in the design of enzyme inhibitors.Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with the perfluorobenzoyl analogue of methazolamide. Implications for the drug design of fluorinated inhibitors.Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with lipophilic sulfonamides.The in vitro and in vivo inhibitory effects of some sulfonamide derivatives on rainbow trout (Oncorhynchus mykiss) erythrocyte carbonic anhydrase activity.Carbonic anhydrase inhibitors. inhibition of cytosolic isozymes I and II and transmembrane, cancer-associated isozyme IX with anions.Effects of melatonin on carbonic anhydrase from human erythrocytes in vitro and from rat erythrocytes in vivo.Carbonic anhydrase inhibitors: Schiff's bases of aromatic and heterocyclic sulfonamides and their metal complexes.Modified β-casein restores thermal reversibility of human carbonic anhydrase II: the salt bridge mechanism.Effects of low molecular weight plasma inhibitors of rainbow trout (Oncorhynchus mykiss) on human erythrocyte carbonic anhydrase-II isozyme activity in vitro and rat erythrocytes in vivo.Purification and characterization of carbonic anhydrase from bovine stomach and effects of some known inhibitors on enzyme activity.Effects of nicotine and vitamin E on carbonic anhydrase activity in some rat tissues in vivo and in vitro.Discovering isozyme-selective inhibitor scaffolds of human carbonic anhydrases using structural alignment and de novo drug design approaches.Antipsychotic agents screened as human carbonic anhydrase I and II inhibitors.Synthesis of new dihydropyrrol-2-one derivatives bearing sulfonamide groups and studies their antibacterial activityCarbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II and IX with some 1,3,4-oxadiazole- and 1,2,4-triazole-thiolsCarbonic anhydrase inhibitors and activators and their use in therapyModulation of carbonic anhydrase activity and its applications in therapyTherapeutic applications of sulfamatesSulfonamide derivatives with protease inhibitory action as anticancer, anti-inflammatory and antiviral agentsSynthesis and Evaluation of New Phthalazine Urea and Thiourea Derivatives as Carbonic Anhydrase InhibitorsAmidine Sulfonamides and Benzene Sulfonamides: Synthesis and Their Biological Evaluation
P2860
Q24794375-01C371EE-23C3-46ED-9346-4AEF79B8966FQ28186386-8943979A-51EB-4C42-8D17-7C82BD637703Q31103548-6B151B06-FC51-4E80-A279-355642EB2B4AQ35056079-E67CA9F6-108B-4114-8DD2-7DD5FBF13802Q36545053-878A3C83-FB8E-4E67-9AC7-12CF5DB0B499Q38773386-A26A6DD5-99B6-40B7-B1B6-94F4BB9F4F53Q42638709-7133D5E0-661D-41B2-96BB-BAA3F08B32F8Q43168863-F37A8067-90F9-4153-ACF0-BA79515D97FBQ44624059-93A1F7E4-B4CD-43E4-BCEB-757FC9B40638Q44624065-4165F928-791D-4ED1-BEE0-7276ED92B3ACQ44624075-2AFD926E-EB28-43B2-A138-04EB414A43FDQ44704011-29A4E400-296A-4860-8A7F-111D5F209C16Q45079145-108794DC-2DAD-438F-8870-2CA828A95E83Q45120191-60FBD4AA-B9F8-4A10-8A44-17B6C8199DB7Q45927485-A408485E-EA9F-4119-94B5-71A0C92CFE2BQ46491971-C69581AB-AF4C-46B1-BFFA-9C66CC394182Q46491985-3F9B5791-318D-45D1-BAC8-FA0B15A4C528Q46491998-7D776371-5799-4B6A-A10A-C4E5E1FA6F4AQ46616542-C02D77A1-2FAC-4FF3-A224-5B6E141153A4Q53080841-997284C3-95F8-43FC-824F-3074E4DB3371Q57331318-72906090-A149-48FA-8B0D-4172A30390CBQ58863247-BE40F724-9182-4F8C-B206-2AD7E6002AA5Q58863271-A6ACD5F3-329C-416C-A13A-83FF2BFACA27Q58863293-3F1874F8-224F-4442-A2AB-5489EA608DFBQ58863297-856E8D62-EBD1-430A-83FC-836299EA4989Q58863308-8190164E-BC54-46A0-8450-68D72E6F5BE9Q59011135-557D15E3-69C0-4164-9EBF-0AE77B591831Q59112246-35787282-1D19-4CFA-A42C-FE8ACB27E9BB
P2860
Applications of carbonic anhydrase inhibitors and activators in therapy
description
im Februar 2002 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2002
@uk
name
Applications of carbonic anhydrase inhibitors and activators in therapy
@en
Applications of carbonic anhydrase inhibitors and activators in therapy
@nl
type
label
Applications of carbonic anhydrase inhibitors and activators in therapy
@en
Applications of carbonic anhydrase inhibitors and activators in therapy
@nl
prefLabel
Applications of carbonic anhydrase inhibitors and activators in therapy
@en
Applications of carbonic anhydrase inhibitors and activators in therapy
@nl
P2860
P1476
Applications of carbonic anhydrase inhibitors and activators in therapy
@en
P2093
Claudiu T Supuran
P2860
P304
P356
10.1517/13543776.12.2.217
P407
P577
2002-02-01T00:00:00Z